Trial Profile
Hypertrophic CARdiomyopathy symptom release by alpha stimulant MIDOdrine
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Midodrine (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Therapeutic Use
- Acronyms Light-CARMIDO
- 08 Dec 2015 New trial record